Source: Eur Respir Rev 2012; 21: 4-5



Rating:

Share or cite this content

Citations should be made in the following way:
Humbert M.. The fifth world symposium on pulmonary hypertension will REVEAL the impact of registries. Eur Respir Rev 2012; 21: 4-5

Member's Comments

No comment yet.

Related content which might interest you: Russian recommendation and registry of pulmonary hypertension Source: International Congress 2017 – Russian Programme 2017 Year: 2017 TOPP: the first international registry in pediatric pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry Source: ERJ Open Res, 7 (3) 00850-2020; 10.1183/23120541.00850-2020 Year: 2021 REVEAL: a contemporary US pulmonary arterial hypertension registry Source: Eur Respir Rev 2012; 21: 8-18 Year: 2012 Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey Source: Eur Respir J 2002; 20: 799-805 Year: 2002 Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019 Year: 2020 The changing epidemiology of pulmonary hypertension: disease characteristics and clinical outcome over two decades of the swiss registry Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Clinical characteristics of pulmonary arterial hypertension in Ireland: results of a national register Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009 Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013 Source: Eur Respir J, 51 (1) 1701603; 10.1183/13993003.01603-2017 Year: 2018 Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry Source: ERJ Open Res, 7 (2) 00046-2021; 10.1183/23120541.00046-2021 Year: 2021 Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model Source: Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017 Year: 2017 Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress Source: Eur Respir J 2015; 46: 879-882 Year: 2015 Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry Source: Eur Respir J, 52 (6) 1801687; 10.1183/13993003.01687-2018 Year: 2018 The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline Source: Eur Respir Rev, 30 (162) 210171; 10.1183/16000617.0171-2021 Year: 2021 Registries for paediatric pulmonary hypertension Source: Eur Respir J 2013; 42: 580-583 Year: 2013 The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007